February 28, 2018

Goldplat plc Q&A with CEO Gerard Kisbey-Green (LON:GDP)

Goldplat plc (LON:GDP) Chief Executive Officer Gerard Kisbey-Green caught up with DirectorsTalk for an exclusive interview to discuss their interim results for the six months ended 31 December 2017 and..

Widecells Group PLC Q&A with CEO João Andrade and Chairman Peter Presland

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chairman Peter Presland caught up with DirectorsTalk for an exclusive interview to discuss the recent Board changes, the launch of..

Veltyco Group PLC Q&A with Whitman Howard (LON:VLTY)

Veltyco Group PLC (LON:VLTY) is the topic of conversation when Whitman Howard’s Equity Researcher Michael Campbell caught up with DirectorsTalk for an exclusive interview   Q1: You published a note..

Rainbow Rare Earths Ltd Q&A with CEO Martin Eales (LON:RBW)

Rainbow Rare Earths Ltd (LON:RBW) Chief Executive Officer Martin Eales caught up with DirectorsTalk for an exclusive interview to discuss their unaudited results for the six months ended 31 December..

Solo Oil Plc Successfully raise £2m for Horse Hill Acquisition

Solo Oil plc (LON:SOLO), announced on 27 February 2018 the launch of a fundraising comprising of a Company sponsored placing (the “Placing”) in conjunction with an offer via PrimaryBid.com (the..

Safestyle UK plc Trading update – Zeus Capital Notes

Safestyle UK Plc (LON:SFE) has announced a trading update this morning warning of increased competitive pressures that have impacted order intake and are expected to result in a 9.5% reduction..

Savannah Resources Plc Scoping Study Underway into the Potential for a Mine Development

Savannah Resources plc (LON:SAV), the AIM quoted resource development company, has today announced that it has appointed internationally recognised Hatch to conduct a Scoping Study of a potential mine development..

OptiBiotix Health plc Capital Reorganisation

OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek a cancellation of its..

Allergy Therapeutics plc Prepares for Manufacturing and Clinical Development of Polyvac

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, today announced that it has signed a contract with AGC Biologics (Heidelberg, Germany) to scale up..

ITV Plc Delivers Strong Operational Performance

ITV Plc (LON:ITV) Today announced its full year results for the year ended 31st December 2017. Full year performance delivers as expected · Total external revenue up 2% to £3,132..

Search

Funds

February 28, 2018

Search

Funds

February 28, 2018

FTSE 100

Funds